{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:45:45Z","timestamp":1793173545370,"version":"4.5.0"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:p>Invasive fungal infections, being opportunistic, lead to severe disease in immunocompromised hosts with an increase in morbidity and mortality. The most common causative agents include Candida, Mucorales, Aspergillus, Cryptococcus, and Pneumocystis species. The common risk factors associated with invasive fungal infections are uncontrolled diabetes mellitus leading to hyperglycemia, neutropenia, immunosuppressive treatment like corticosteroids, and primary and secondary immunodeficiency disorders, especially acquired immunodeficiency syndrome. Various molecular therapeutic agents used for targeted therapy are also associated with an increase in opportunistic infections as they involve many signaling pathways related to immunity against pathogens. Prompt diagnosis of diseases caused by these invasive fungal infections is necessary because immunosuppression increases the risk of fatality, and treatment should be initiated immediately based on susceptibility and recommendations.<\/jats:p>","DOI":"10.4103\/jfmpc.jfmpc_1582_24","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T06:00:13Z","timestamp":1752904813000},"page":"2643-2652","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Invasive fungal infections and the management in immunocompromised conditions"],"prefix":"10.4103","volume":"14","author":[{"given":"Garima","family":"Anandani","sequence":"first","affiliation":[{"name":"Department of Pathology, AIIMS Rajkot, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuri","family":"Bhise","sequence":"additional","affiliation":[{"name":"Department of Microbiology, AIIMS Rajkot, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Microbiology, AIIMS Rajkot, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41577-022-00826-w","article-title":"Immune responses to human fungal pathogens and therapeutic prospects","volume":"23","author":"Lionakis","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/13693780801971450","article-title":"Cell-mediated immunity to fungi:A reassessment","volume":"46","author":"Romani","year":"2008","journal-title":"Med Mycol"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"omac075","DOI":"10.1093\/omcr\/omac075","article-title":"Subglottic mucormycosis in a COVID-19 patient:A rare case report","volume":"7","author":"Amirzargar","year":"2022","journal-title":"Oxford Med Case Rep"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/biologics3010004","article-title":"Management of invasive infections in diabetes mellitus:A comprehensive review","volume":"3","author":"Khanam","year":"2023","journal-title":"Biologics"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"S307","DOI":"10.1093\/mmy\/myy136","article-title":"Invasive fungal infections in the immunocompromised host:Mechanistic insights in an era of changing immunotherapeutics","volume":"57","author":"Eades","year":"2019","journal-title":"Med Mycol"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41577-018-0004-8","article-title":"C-type lectins in immunity and homeostasis","volume":"18","author":"Brown","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"e2011007","DOI":"10.4084\/mjhid.2011.007","article-title":"Invasive candidiasis in non-hematological patients","volume":"3","author":"Mikulska","year":"2011","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R9-20250804","first-page":"223","article-title":"Virulence factors of Candida species","volume":"36","author":"Yang","year":"2003","journal-title":"J Microbiol Immunol Infect"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1086\/504491","article-title":"Contemporary tools for the diagnosis and management of invasive mycoses","volume":"43","author":"Alexander","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s12105-020-01127-1","article-title":"Palatal erythema with histological psoriasiform pattern:An enigmatic oral finding shared by a range of conditions","volume":"14","author":"Zlotogorski","year":"2020","journal-title":"Head Neck Pathol"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00405-020-05865-4","article-title":"Management of laryngeal candidiasis:An evidence-based approach for the otolaryngologist","volume":"277","author":"Valente","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/JCM.01385-07","article-title":"Multicenter evaluation of the Candida albicans\/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles","volume":"46","author":"Shepard","year":"2008","journal-title":"J Clin Microbiol"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3390\/antibiotics11060718","article-title":"Diagnosis and treatment of invasive candidiasis","volume":"11","author":"Barantsevich","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/JCM.01900-06","article-title":"Correlation of neo-sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole","volume":"45","author":"Espinel-Ingroff","year":"2007","journal-title":"J Clin Microbiol"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis:2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1086\/313803","article-title":"Zygomycosis in the 1990s in a tertiary-care cancer center","volume":"30","author":"Kontoyiannis","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3390\/microorganisms9030523","article-title":"Epidemiology of mucormycosis in India","volume":"9","author":"Prakash","year":"2021","journal-title":"Microorganisms"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/myc.13187","article-title":"Epidemiology, clinical features, diagnosis, and treatment of cerebral mucormycosis in diabetic patients:A systematic review of case reports and case series","volume":"63","author":"Chegini","year":"2020","journal-title":"Mycoses"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijscr.2018.11.057","article-title":"Case report:Disseminated pulmonary mucormycosis involving spleen in diabetic patient with aggressive surgical approach","volume":"54","author":"Alqhamdi","year":"2019","journal-title":"Int J Surg Case Rep"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.4103\/jfmpc.jfmpc_1479_21","article-title":"Laboratory diagnosis of mucormycosis:Present perspective","volume":"11","author":"Gupta","year":"2022","journal-title":"J Family Med Prim Care"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/10668969221099626","article-title":"Histopathological study of mucormycosis in post-COVID-19 patients and factors affecting it in a tertiary care hospital","volume":"31","author":"Sree Lakshmi","year":"2023","journal-title":"Int J Surg Pathol"},{"key":"R24-20250804","first-page":"406","article-title":"Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect mucormycosis in biopsy and blood specimens","volume":"5","author":"Badiee","year":"2013","journal-title":"Iran J Microbiol"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hed.20055","article-title":"Tracheal mucormycosis presented as an intraluminal soft tissue mass","volume":"26","author":"Wolf","year":"2004","journal-title":"Head Neck"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"247","DOI":"10.30699\/ijmm.15.2.247","article-title":"Mucormycosis mimicking tracheal tumor:A case report","volume":"15","author":"Ansari","year":"2021","journal-title":"Iranian J Med Microbiol"},{"key":"R28-20250804","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.1128\/IAI.01551-06","article-title":"Role of neutrophils in invasive aspergillosis","volume":"74","author":"Feldmesser","year":"2006","journal-title":"Infect Immun"},{"key":"R29-20250804","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1517\/14656566.9.2.193","article-title":"Evolving strategies in the management of aspergillosis","volume":"9","author":"Magill","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"R30-20250804","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/MCP.0b013e328010c812","article-title":"Allergic bronchopulmonary aspergillosis:A US perspective","volume":"13","author":"Virnig","year":"2007","journal-title":"Curr Opin Pulm Med"},{"key":"R31-20250804","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4103\/0970-2113.120623","article-title":"Fruiting bodies of aspergillus:An unusual finding in histopathology","volume":"30","author":"Anila","year":"2013","journal-title":"Lung India"},{"key":"R32-20250804","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2147\/COPD.S4229","article-title":"Management of invasive aspergillosis in patients with COPD:Rational use of voriconazole","volume":"4","author":"Ader","year":"2009","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"R33-20250804","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1378\/chest.08-2586","article-title":"Allergic bronchopulmonary aspergillosis","volume":"135","author":"Agarwal","year":"2009","journal-title":"Chest"},{"key":"R34-20250804","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1164\/rccm.200505-727SO","article-title":"Current approaches to diagnosis and treatment of invasive aspergillosis","volume":"173","author":"Segal","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"R35-20250804","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/cid\/cir185","article-title":"Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients","volume":"52","author":"Luong","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R36-20250804","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis:2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R37-20250804","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1086\/423380","article-title":"Combination antifungal therapy for invasive aspergillosis","volume":"39","author":"Marr","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R38-20250804","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/MD.0b013e318274cd77","article-title":"Central nervous system aspergillosis:A series of 14 cases from a general hospital and review of 123 cases from the literature","volume":"91","author":"Kourkoumpetis","year":"2012","journal-title":"Medicine"},{"key":"R39-20250804","first-page":"1","article-title":"Cryptococcus Neoformans:From Human Pathogen to Model Yeast","author":"Heitman","year":"2011","journal-title":"American Society of ?Microbiology"},{"key":"R40-20250804","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3201\/eid0703.017302","article-title":"Cryptococcus neoformans infection in organ transplant recipients:Variables influencing clinical characteristics and outcome","volume":"73","author":"Husain","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"R41-20250804","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1086\/322597","article-title":"Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy","volume":"335","author":"Pappas","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R42-20250804","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/13693780701390140","article-title":"Study of common functional genetic polymorphisms of FCGR2A, 3A, and 3B genes and the risk for cryptococcosis in HIV-uninfected patients","volume":"45","author":"Meletiadis","year":"2007","journal-title":"Med Mycol"},{"key":"R43-20250804","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1016\/j.jinf.2006.10.002","article-title":"Immune dysfunction in HIV-seronegative, cryptococcus gattii meningitis","volume":"54","author":"Brouwer","year":"2007","journal-title":"J Infect"},{"key":"R44-20250804","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.4049\/jimmunol.174.3.1746","article-title":"IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis","volume":"174","author":"Siddiqui","year":"2005","journal-title":"J Immunol"},{"key":"R45-20250804","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1086\/368091","article-title":"The changing epidemiology of cryptococcosis:An update from population-based active surveillance in 2 large metropolitan areas, 1992-2000","volume":"36","author":"Mirza","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R46-20250804","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1590\/S0036-46651997000600003","article-title":"Cerebrospinal fluid profiles in acquired immunodeficiency syndrome with and without neurocryptococcosis","volume":"39","author":"Garlipp","year":"1997","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"R47-20250804","first-page":"2997","article-title":"Cryptococcus neoformans","author":"Perfect","year":"2005","journal-title":"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases"},{"key":"R48-20250804","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1086\/597262","article-title":"Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa","volume":"487","author":"Jarvis","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R49-20250804","first-page":"1","article-title":"Guidelines for preventing opportunistic infections among HIV-infected persons\u20142002. Recommendations of the U. S. Public Health Service and the Infectious Diseases Society of America","volume":"51","author":"Kaplan","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"R50-20250804","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1086\/498158","article-title":"Has the name been changed?It has for most researchers","volume":"41","author":"Cushion","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R51-20250804","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1099\/jmm.0.45893-0","article-title":"Pneumocystis carinii pneumonia in Hong Kong:A 10-year retrospective study","volume":"55","author":"Hui","year":"2006","journal-title":"J Med Microbiol"},{"key":"R52-20250804","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1258\/ijsa.2008.008428","article-title":"Pneumocystis-associated organizing pneumonia as a manifestation of immune reconstitution inflammatory syndrome in an HIV-infected individual with a normal CD4+T-cell count following antiretroviral therapy","volume":"20","author":"Mori","year":"2009","journal-title":"Int J STD AIDS"},{"key":"R53-20250804","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1440-1843.2009.01583.x","article-title":"Early recurrence of Pneumocystis jiroveci pneumonia in two HIV-infected patients:Linking infection relapse and immune reconstitution syndrome","volume":"14","author":"Kolditz","year":"2009","journal-title":"Respirology"},{"key":"R54-20250804","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3390\/jof8111167","article-title":"The pathogenesis and diagnosis of Pneumocystis jiroveci pneumonia","volume":"8","author":"Apostolopoulou","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"R55-20250804","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1128\/JCM.05267-11","article-title":"Diagnostic accuracy of serum 1,3-\u00df-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis:Systematic review and meta-analysis","volume":"50","author":"Onishi","year":"2012","journal-title":"J Clin Microbiol"},{"key":"R56-20250804","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/j.1469-0691.2010.03400.x","article-title":"Real-time PCR assay-based strategy for differentiation between active pneumocystis jirovecii pneumonia and colonization in immunocompromised patients","volume":"17","author":"Alanio","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"R57-20250804","doi-asserted-by":"crossref","first-page":"792","DOI":"10.7326\/0003-4819-124-9-199605010-00003","article-title":"Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group","volume":"124","author":"Safrin","year":"1996","journal-title":"Ann Intern Med"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1582_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:24:20Z","timestamp":1787844260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1582_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1582_24","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"2024-09-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}